Lifyorli (relacorilant) is a new medicine used to treat certain types of cancer. The FDA approved Lifyorli in March 2026 to be used in combination with a particular chemotherapy medicine (paclitaxel) ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

How Does Libtayo Work for Non-Small-Cell Lung Cancer (NSCLC)? Libtayo is a specific kind of medicine called immunotherapy. Immunotherapies work by helping your body’s own immune system work to fight ...

(CNN) — Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

(NEXSTAR) – An advance in vaccine technology is showing promise toward fighting the second-most common cause of death in the United States, cancer. Scientists are working on developing mRNA vaccines ...